Who invested in VentaoRX?
VentaoRX's investors include BioAdvance, Foresite and Versant Ventures/ Abingworth.
United States · Series B startup
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$42Mraised across 1 round since 2017, from 1 source
VentaoRX's investors include BioAdvance, Foresite and Versant Ventures/ Abingworth.
VentaoRX has raised $42M across 1 round since 2017.
VentaoRX's most recent round was a Series B of $42M in Aug 2017.
Its most recent round, $42M in Aug 2017, is also its largest on record.
VentaoRX's first round on record, in Aug 2017, was backed by BioAdvance, Foresite and Versant Ventures/ Abingworth.
VentaoRX's latest named round is a Series B, in Aug 2017.
VentaoRX is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.